Your browser doesn't support javascript.
loading
Advances in the Study of Chemokine-like Factor Superfamily Members in Tumors / 中国肺癌杂志
Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-971178
Biblioteca responsável: WPRO
ABSTRACT
Chemokine-like factor-like MARVEL transmembrane domain containing member/chemokine-like factor superfamily member (CMTM/CKLFSF) including CKLF and CMTM1-CMTM8 are a new family of proteins linking chemokines and transmembrane superfamilies. CMTM not only have broad chemotactic activities, but also associate with hematopoietic system, immune system, and tumor development and metastasis closely. CMTM proteins are involved in key biological processes of cancer development, which include activation and recycling of growth factor receptors, cell proliferation and metastasis, and regulation of the tumor immune microenvironment. This is a new focus of research on the relationship between CMTM and tumors, because CMTM4/CMTM6 can be considered as a regulator for programmed cell death ligand 1 (PD-L1). This paper reviews the role of CMTM family members on cancer, especially in tumor growth, metastasis and immune escape, summarize the latest findings on the relationship between CMTM and non-small cell lung cancer, and explores the potential clinical value of CMTM as a novel drug target or biomarker.
.
Assuntos

Texto completo: Disponível Base de dados: WPRIM (Pacífico Ocidental) Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Quimiocinas / Proliferação de Células / Microambiente Tumoral / Proteínas com Domínio MARVEL / Neoplasias Pulmonares Limite: Humanos Idioma: Chinês Revista: Chinese Journal of Lung Cancer Ano de publicação: 2023 Tipo de documento: Artigo
Texto completo: Disponível Base de dados: WPRIM (Pacífico Ocidental) Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Quimiocinas / Proliferação de Células / Microambiente Tumoral / Proteínas com Domínio MARVEL / Neoplasias Pulmonares Limite: Humanos Idioma: Chinês Revista: Chinese Journal of Lung Cancer Ano de publicação: 2023 Tipo de documento: Artigo
...